BnJ Biopharma

BiotechnologySeedIncheon, South Koreabnjbio.com

Latest round

Seed

Last raised

Jul 2023

Total raised

Undisclosed

Investors

4

About BnJ Biopharma

Based in Incheon, South Korea, and founded in 2021, BnJ Biopharma Inc. operates as a biotechnology firm developing anticancer medications based on intratumoral diversity data. In December 2023, BnJ Biopharma Inc. As of December 2023, Dong Jae-joon is the Chief Executive Officer (CEO) of the company. BnJ Biopharma specializes in anticancer drug development using intratumor diversity data. The company creates an advanced approach to increasing early-stage anticancer drug development through intratumoral differences insights, which could reduce the typical decade-long process to five years. This ground-breaking strategy aims at fighting resistance in existing anticancer drugs, promising significant advances in the field.

Who invested in BnJ Biopharma

4 investors across 2 rounds

See all investors in BnJ Biopharma

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Jul 24, 2023

    Amount

    Undisclosed

    Investors

    Locked

  2. Seed

    May 31, 2022

    Amount

    Undisclosed

    Investors

    Locked

Questions about BnJ Biopharma

Who invested in BnJ Biopharma?

BnJ Biopharma has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has BnJ Biopharma raised?

BnJ Biopharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did BnJ Biopharma last raise money?

BnJ Biopharma's most recent round on record is a Seed, in Jul 2023.

What does BnJ Biopharma do?

Based in Incheon, South Korea, and founded in 2021, BnJ Biopharma Inc.

Where is BnJ Biopharma headquartered?

BnJ Biopharma is headquartered in Incheon, South Korea.

Which VCs invest in companies like BnJ Biopharma?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at BnJ Biopharma's stage. Their profiles are linked below.

Raising like BnJ Biopharma? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.